WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000063368) RECOMBINANT PROTEIN UK114 AND ITS USE IN THERAPY AND DIAGNOSTICS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/063368    International Application No.:    PCT/EP2000/003003
Publication Date: 26.10.2000 International Filing Date: 05.04.2000
Chapter 2 Demand Filed:    15.11.2000    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: ZETESIS S.P.A. [IT/IT]; Via Filodrammatici 10, I-20122 Milano (IT) (For All Designated States Except US).
NAKTINIS, Vytautas [LT/IT]; (IT) (For US Only).
CONCAS BENEVELLI, Daniela [IT/IT]; (IT) (For US Only).
BERRA, Bruno [IT/IT]; (IT) (For US Only).
COLOMBO, Irma [IT/IT]; (IT) (For US Only).
RONCHI, Severino [IT/IT]; (IT) (For US Only).
BARTORELLI, Alberto [IT/IT]; (IT) (For US Only).
BUMELIS, Viadas, Algirdus [LT/IT]; (IT) (For US Only)
Inventors: NAKTINIS, Vytautas; (IT).
CONCAS BENEVELLI, Daniela; (IT).
BERRA, Bruno; (IT).
COLOMBO, Irma; (IT).
RONCHI, Severino; (IT).
BARTORELLI, Alberto; (IT).
BUMELIS, Viadas, Algirdus; (IT)
Agent: MINOJA, Fabrizio; Bianchetti Bracco Minoja S.r.l., Via Rossini, 8, I-20122 Milano (IT)
Priority Data:
09/291,332 15.04.1999 US
Title (EN) RECOMBINANT PROTEIN UK114 AND ITS USE IN THERAPY AND DIAGNOSTICS
(FR) PROTEINE DE RECOMBINAISON UK114 ET SON UTILISATION A DES FINS THERAPEUTIQUES ET DIAGNOSTIQUES
Abstract: front page image
(EN)A new protein obtained through recombinant DNA techniques which can be used in diagnostics and in therapy, in particular for treating tumors, a cDNA molecule encoding such a protein, a process for preparing it and the expression vectors and host cells used in such a process.
(FR)L'invention se rapporte à une nouvelle protéine obtenue par des techniques de recombinaison, qui peut être utilisée à des fins thérapeutiques et diagnostiques, notamment pour le traitement des tumeurs. L'invention se rapporte également à une molécule d'ADNc codant pour une telle protéine, à un procédé de préparation de ladite protéine et aux vecteurs d'expression et cellules hôtes mis en oeuvre par un tel procédé.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)